Questioning the Addition of Fluoroquinolone on Mortality in Severe Community-Acquired Pneumonia: A multicenter study in Korea
In patients with sCAP, outcomes did not differ significantly between APBL monotherapy and FQ combination therapy. This suggests that even in severe CAP, an individualized treatment strategy based on the causative agent may be more appropriate than indiscriminate combination therapy.
Authors
- Ji Hyun Yun (ORCID: https://orcid.org/0000-0001-5263-5639)
- Min Joo Choi (ORCID: https://orcid.org/0000-0002-2739-0948)
- Bongyoung Kim (ORCID: https://orcid.org/0000-0002-5029-6597)
- Ki Tae Kwon (ORCID: https://orcid.org/0000-0003-4666-0672)
- Yong Chan Kim (ORCID: https://orcid.org/0000-0001-5081-7906)
- Se Ju Lee (ORCID: https://orcid.org/0000-0001-9779-5062)
- Taehyen Kim
- Won Suk Choi (ORCID: https://orcid.org/0000-0001-5874-4764)
- Soyoon Hwang (ORCID: https://orcid.org/0000-0003-3618-174X)
- Hyeri Seok (ORCID: https://orcid.org/0000-0002-2032-9538)
- Yeseul Na
- So Hee Kim
- Jin Soo Lee (ORCID: https://orcid.org/0000-0001-7862-5519)
Institutions
- Inha University (KR)
- Yonsei University (KR)
- Korea University (KR)
- Severance Hospital (KR)
- Kyungpook National University Hospital (KR)
- Konkuk University Medical Center (KR)
- Hanyang University Seoul Hospital (KR)
- Catholic Kwandong University International St. Mary's Hospital (KR)
- Korea University (JP)
Publication Details
- Journal
- Journal of Microbiology Immunology and Infection
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1016/j.jmii.2025.04.004
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00